2.57
8.21%
-0.23
Gritstone Bio Inc stock is currently priced at $2.57, with a 24-hour trading volume of 2.25M.
It has seen a -8.21% decreased in the last 24 hours and a -9.51% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.78 pivot point. If it approaches the $2.52 support level, significant changes may occur.
Gritstone Bio Inc Stock (GRTS) Financials Data
Gritstone Bio Inc (GRTS) Revenue 2023
GRTS reported a revenue (TTM) of $2.63 million for the quarter ending September 30, 2023, a -72.95% decline year-over-year.
Gritstone Bio Inc (GRTS) Net Income 2023
GRTS net income (TTM) was -$138.96 million for the quarter ending September 30, 2023, a -17.60% decrease year-over-year.
Gritstone Bio Inc (GRTS) Cash Flow 2023
GRTS recorded a free cash flow (TTM) of -$138.38 million for the quarter ending September 30, 2023, a -20.26% decrease year-over-year.
Gritstone Bio Inc (GRTS) Earnings per Share 2023
GRTS earnings per share (TTM) was -$1.24 for the quarter ending September 30, 2023, a +10.79% growth year-over-year.
Gritstone Bio Inc Stock (GRTS) Latest News
Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?
Zacks Investment Research
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GlobeNewswire Inc.
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research
About Gritstone Bio Inc
Gritstone Oncology Inc. is engaged in the discovery and development of cancer immunotherapies. The company focuses on developing tumor-specific neo-antigens-based therapies for non-small cell lung cancer. Gritstone Oncology Inc. has a strategic collaboration with bluebird bio, Inc. The company was incorporated in 2015 and is based in San Francisco, California with operations in Cambridge, Massachusetts.
Cap:
|
Volume (24h):